Venture Life Share Discussion Threads

[multibagger] 05/9/2018 10:17

APAD - Commiserations - I share your pain as I sold out too early a couple of years ago as dear old HMRC needed feeding sharpish...need to look again if it is worth picking up at this price !

[apad] 05/9/2018 10:16

Managerspeak!
"Despite these headwinds, we are continuing to hit important strategic milestones for our transformation across our three business units, where Xaar owns world-leading technology.'

[multibagger] 05/9/2018 10:14

IDEA acquisition of InspectionXpert in the US announced today...

Another very impressive and strategic acquisition bringing a host of high profile customers such from the aviation industry.

Firstly, IX have a lot of local US SME customers who could potentially benefit from the MAGA programme being pursued politically. In fact given we are earning $2.8m from over 1000 customers, it is probable that most of the customer base is small and medium enterprises.

Secondly, we could benefit from the strength of the USD which is what the revenue is likely to be largely based. The level of recurrent SaaS business of IX is exceptional ($2.7m out of $2.8m revenues or 96.41%) and I am sure that IDEA will leverage that and also the opportunities to cross sell from the suite of IDEA products.

So I would expect this to grow quite quickly and with the dynamism of IDEA management this will be another excellent revenue and profitable catalyst in the near to medium term.

[attrader] 05/9/2018 08:38

Yup Irish puma ..

[valhamos] 05/9/2018 08:03

Yes - ahead of expectations for year to end March 2019. In last year's comparison and KNOS is still a strong hold for me.

[thetrophyman] 04/9/2018 22:31

A bit random I know but could anyone recommend a good stock screener/filter? I have free access to one through my SIPP provider but I'm just not convinced its completely up to date. Any thoughts welcome and thanks in advance

[hydrus] 04/9/2018 21:06

Mod yes it briefly got to one trillion dollar Mcap today. Jane - understood, I don't think I'd go above 10% as an initial outlay and at that level I'd have to think it was a really excellent opportunity.

[janeann] 04/9/2018 20:52

I went in reasonably large with acso and for me pretty large with zoo; but got my fingers burnt years ago on trt so a little wary getting caught like that again. Mind I wasn't alone with trt.

[modform] 04/9/2018 20:44

Since the advfn mobile app update for Android , I seem to be able to see the charts and post on BB, but the app doesn't show any delayed prices, they all appear as blank. I am using S7 with O2 network, anyone else has the same problem? There's no stopping AMZN hydrus

[hydrus] 04/9/2018 20:23

Thanks Jane. I meant initial outlay yes. I suspect my propensity to go in large initially is relatively unusual. Well done on your stock picks.

[janeann] 04/9/2018 20:11

I take stake to mean outlay rather than value so generally its info I don't work on, mainly cos I try and top slice and buy back (or did!), and as the whole value goes up the stake can look very small; so working stakes out at purchase time is difficult. I can do value roughly; acso is over 15% ; arc is small c5% mainly cos if it did fallout of favour one would never ever sell it, zoo - c 10% - liked zoo a lot and got a lot early - but far later than you. Pctn c5% ZTF 7.5%. Biom small until I know more less than 1.

and cash about 8% which has its uses e.g. day trading the likes of acso for the odd glass of wine!

[hydrus] 04/9/2018 19:49

Jane do you mind me asking what sort of stake (percentage of portfolio terms) you put in those sort of investments? I put in quite decent stakes if I feel the opportunity is excellent. For example, I put over 10% of my portfolio in ZOO at average of 11p so the impact on my overall returns has been very good. With BIOM it's about 4% currently. ZOO now makes up about 35% of my portfolio, despite already extracting good profits on my entire initial stake. BVXP and BUR combined are about 22%. Again a lot of that is gains.

[janeann] 04/9/2018 19:44

yes hydrus; I have been lucky the last couple of years with acso, arc prsm + zoo and real stars don't come along that often. will start to look ore closely now I have taken an intitial stake and decide where it leads.

[hydrus] 04/9/2018 19:18

Worth saying also that I understood the ZOO business model and market opportunity better when I invested there. I keep hunting for nanocaps with potential. I exited YOO (on TSX) with a 35% loss on my opening stake. Didn't work out but I don't expect them all too. Key for me is they need to have a track record of organic revenue growth with a potentially large market opportunity. If it emerges that growth is slowing and it's not clear why then I get out. If you get even one right every so often the rewards can be simply enormous. Good alongside more established high quality micro and mid caps growing quickly.

[hydrus] 04/9/2018 18:37

No problem Jane. I'm not convinced it has the same potential as ZOO although there are some parallels in that it has previous disappointed and there are clearly stale bulls present. The impact, like with ZOO when it was in single and low double digit figures, is that the market cap doesn't reflect the current positive trading. Put it this way, if BIOM came to the market now with the following characteristics:- organic growth > 45% - net cash of £2m- revenue likely to be circa £9m with track record of significant growth over last five years or so- just turned profitable - some interesting opportunities in their secondary market (bioplastics)What would the Mcap be? I suspect £40m plus . It's currently £12m.I don't fully trust management partly because they don't have enough of a stake. However at this price it seems a no brainier for some decent gains over coming months.

[big7ime] 04/9/2018 18:22

It was over 7m last yr APAD, wont the mkt be disappointed if the growth is that small? Or is it all about the forward statement re troponin

[janeann] 04/9/2018 18:18

prefer trusts personally; that's why I investigated further. will certainly look at it.

ps hydrus - finally took the plunge in biom - liked the update yesterday. thanks

[thelongandtheshortandthetall] 04/9/2018 18:09

Thanks Janeann
I'll be investing. funds and trusts suit me at the moment.
Cheers

[janeann] 04/9/2018 18:04

yes it will be interesting ........... A prospectus for the company will be published on 17 September with the share offer closing on 12 October and trading in the shares starting a week later. Investec Bank is broker to the issue

[apad] 04/9/2018 17:57

Error in my forecast revenue for BVXP.
It is 8.5, cf tintin forecast of 8.
Careless!
apad

[thelongandtheshortandthetall] 04/9/2018 17:55

Wonderful.
Ive been waiting for Fundsmith Jnr. (much better name than smithson :))

Looking forward to seeing his stock picks within this trust. I suspect it'll reveal a few ideas that will interest us here.

[apad] 04/9/2018 17:46

"SEPTEMBER 04 2018
Fundsmith, the fund management business set up by veteran City stockpicker Terry Smith, says it will absorb all of the launch costs of its new £250m investment trust in a move that will reignite the debate over investment fees charged to retail investors.

The Smithson Investment Trust will target small and mid-cap global companies, and is intended to be the “son of” Fundsmith’s £17bn equity fund, which has grown rapidly since its launch nearly eight years ago to become one of Europe’s 20 largest actively management funds.

Fundsmith said it would “bear all of the costs” associated with the planned launch of Smithson next month, meaning that for every £10 invested in the issue, shareholders “will receive £10 of value on day one of trading”."

[gsbmba99] 04/9/2018 14:09

BVXP - forgot to say there may be some headwind from US VitD. DiaSorin Q2 concall transcript highlights -10% YoY reduction in US VitD for them (think it was -5% in Q1). Some of that may be specific to DiaSorin, however, they also said that CIGNA, a large US insurer, had decided not to reimburse for VitD testing used for "screening" purposes as opposed to "diagnostic" purposes. Let's hope CIGNA is not the first of many insurers to adopt this policy. DiaSorin did say that this had happened before in Australia and France and things eventually returned to normal. I believe DiaSorin was early in VitD and don't have a high throughput machine so this may also reflect some loss of share to the big four/five.

[big7ime] 04/9/2018 13:43

Thanks gsbm, excellent post